PGP and systemic lupus erythematosus: Our group previously related increased P-gp serum levels to disease activity as well as resistance to immunosuppressor agents and DMARDs in RA and SLE patients [16,17]; the findings of this study support this perspective by showing that serum P-gp could have an essential role in steroid resistance in rheumatic diseases such as SLE.